stockrow
Friday 6 November 2026
Export WRBY’s income statement to Excel — free account
Warby Parker Inc.
WRBY Healthcare Medical Instruments & Supplies
Warby Parker Inc.’s revenue for fiscal 2025 (year ended December 2025) was $871.9 million, up 13.0% from fiscal 2024.
- Revenue
- +10.4%
- EPS
- −20.0%
- Free cash flow
- −30.3%
Quarter to September 2026, against a year earlier
26.05
4.76
+22.36%
Follow WRBY
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
1,387.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Piotroski F-Score |
6 | 7 | 5 | 4 | — | — | — | — |
Altman Z-Score |
4.73 | 5.12 | 3.06 | 2.57 | 12.03 | — | — | — |
P/S ratio |
3.07 | 3.78 | 2.61 | 2.75 | 6.13 | 6.04 | 6.04 | — |
Altman Z″-Score (non-manufacturers) |
(0.22) | (0.65) | (1.50) | (1.80) | (0.77) | 0.21 | — | — |
P/FCF ratio |
61.11 | 83.96 | 238.95 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Beneish M-Score |
(2.64) | (3.09) | (3.26) | 86.63 | (2.94) | — | — | — |
P/Operating CF |
114.95 | 146.37 | 128.00 | 69.09 | (104.13) | (1,619.11) | (1,619.11) | — |
P/B ratio |
7.27 | 8.57 | 5.80 | 5.75 | 11.60 | 0.00 | 0.00 | — |
Price to Tangible BV |
7.27 | 8.57 | 5.80 | 5.75 | 11.60 | 0.00 | 0.00 | — |
EV/Sales |
2.74 | 3.45 | 2.29 | 2.41 | 5.66 | 5.50 | 5.50 | — |
EV/EBITDA |
49.36 | 136.73 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Operating CF |
21.54 | 26.94 | 25.12 | 138.72 | (95.67) | 96.98 | 96.98 | — |
EV/FCF |
54.57 | 76.64 | 209.32 | (28.88) | (38.02) | (196.95) | (196.95) | — |
Quick Ratio |
1.93 | 1.96 | 1.72 | 1.62 | 2.18 | 2.99 | 0.75 | — |
Current Ratio |
2.35 | 2.50 | 2.35 | 2.27 | 2.78 | 3.42 | 1.21 | — |
Net Debt/EBITDA |
(5.92) | (13.06) | 7.10 | 2.64 | 2.10 | 8.29 | (4.31) | — |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Asset Turnover |
1.25 | 1.23 | 1.17 | 1.19 | 1.22 | 1.77 | 0.00 | — |
Operating CF/Net income |
67.51 | (4.84) | (0.97) | (0.09) | 0.20 | (0.59) | (0.37) | — |
Capex/Depreciation |
(1.25) | (1.29) | (1.29) | (1.87) | (2.25) | (1.13) | (2.25) | — |
Interest Coverage |
0.64 | 2.84 | 7.80 | 85.08 | (414.01) | (573.53) | 0.86 | — |
| 0.46% | (6.35%) | (21.48%) | (38.56%) | (358.15%) | 28.86% | 29.69% | — | |
| 0.23% | (3.24%) | (11.00%) | (21.87%) | (35.56%) | (25.15%) | 0.00% | — | |
ROIC |
(4.10%) | (21.91%) | (53.00%) | (89.04%) | (303.52%) | 0.00% | 0.00% | — |
Return on Tangible Assets |
0.42% | (5.57%) | (19.51%) | (36.36%) | (48.87%) | (16.49%) | (57.71%) | — |
Average Days of Receivables |
1.38 | 0.92 | 0.97 | 0.88 | 0.67 | 0.56 | 1.10 | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
54.58% | 59.24% | 65.28% | 75.62% | 85.32% | 73.04% | 60.67% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
3.96% | 6.13% | 10.53% | 16.39% | 19.81% | 11.41% | 2.29% | — |
Graham Net Nets |
0.00 | 0.00 | 0.01 | 0.01 | 0.05 | 0.11 | 0.11 | — |
Graham Number |
1.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
0.07% | (0.70%) | (3.62%) | (6.77%) | (4.28%) | (1.76%) | (1.76%) | — |
Free Cash Flow Yield |
1.64% | 1.19% | 0.42% | (3.02%) | (2.43%) | (0.46%) | (0.46%) | — |
Revenue per Share |
7.11 | 6.41 | 5.71 | 5.20 | 7.59 | 7.42 | 7.07 | — |
Operating CF per Share |
0.90 | 0.82 | 0.52 | 0.09 | (0.45) | 0.62 | 0.41 | — |
Capex per Share |
(0.55) | (0.53) | (0.46) | (0.52) | (0.68) | (0.38) | (0.62) | — |
Free Cash Flow per Share |
0.36 | 0.29 | 0.06 | (0.43) | (1.13) | 0.24 | (0.21) | — |
Cash per Share |
2.33 | 2.11 | 1.85 | 1.81 | 3.60 | 5.92 | 1.06 | — |
Shareholders Equity per Share |
3.00 | 2.82 | 2.57 | 2.49 | 4.01 | (3.74) | 0.00 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
3.00 | 2.82 | 2.57 | 2.49 | 4.01 | (3.74) | 0.00 | — |
Free Cash Flow |
43.74 | 34.71 | 7.32 | (49.81) | (80.51) | 12.69 | (11.24) | — |
Working Capital |
202.31 | 195.69 | 171.53 | 165.01 | 209.88 | 254.60 | 15.82 | — |
Capital Expenditures |
(67.05) | (64.03) | (53.67) | (60.18) | (48.51) | (20.07) | (32.63) | — |
Net Current Asset Value |
(0.75) | (10.37) | 20.09 | 12.51 | 173.33 | (282.91) | 91.68 | — |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.08 | 0.08 | 0.08 | 0.10 | 0.09 | 0.05 | 0.09 | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
0.29 | 0.29 | 0.27 | 0.23 | 0.19 | 0.21 | 0.17 | — |
Cash ROIC |
6.69% | 5.84% | 1.41% | (10.06%) | (14.84%) | 10.94% | (20.28%) | — |
Accounts Receivable Turnover |
333.23 | 413.91 | 416.78 | 492.88 | 678.97 | 458.08 | 431.02 | — |
Accounts Payable Turnover |
14.46 | 14.99 | 14.08 | 9.95 | 6.22 | 4.14 | 3.77 | — |
Inventory Turnover |
8.29 | 6.01 | 4.65 | 4.08 | 4.67 | 4.84 | 4.40 | — |
Average Days of Payables |
29.08 | 24.92 | 26.91 | 29.52 | 50.55 | 92.02 | 92.41 | — |
Days of Inventory on Hand |
40.48 | 55.46 | 74.59 | 97.76 | 93.43 | 86.79 | 70.44 | — |
Average Receivables |
2.62 | 1.86 | 1.61 | 1.21 | 0.80 | 0.86 | 0.86 | — |
Average Payables |
27.75 | 22.99 | 21.62 | 25.84 | 35.84 | 39.05 | 39.05 | — |
Average Inventory |
48.43 | 57.29 | 65.54 | 62.97 | 47.78 | 33.45 | 33.45 | — |
Average Assets |
698.70 | 628.40 | 574.51 | 504.68 | 442.70 | 222.38 | 0.00 | — |
Average Common Equity |
353.90 | 320.93 | 294.22 | 286.32 | 43.95 | (193.77) | (193.77) | — |
Columns are period end dates · fundamentals updated 5 Nov 2026